Corrs Chambers Westgarth

The judgment in ASIC's case against Star's top executives and directors sounds a warning that board members need to proactively test information and serves as a "stark reminder" to general counsel that their duties are owed to the company, not management, experts tell Lawyerly.

Facing a class action over the paint job on its Corollas, Toyota has denied the vehicles contained a defect that caused the paint to peel when exposed to sunlight.

Among top-tier firms, Gilbert + Tobin and Ashurst have reported the smallest gaps in the pay of male and female employees, while Corrs Chambers Westgarth and Herbert Smith Freehills Kramers have reported the largest pay disparities.

Mayne Pharma has launched a bid for a $13.6 million gross sum costs order against US drug maker Cosette, after winning one of numerous legal challenges over the termination of a $672 million merger agreement.

Developer Vantager has been ordered to sell off six properties to satisfy a judgment debt and compensate buyers who overpaid for a Denham Court property by more than $34 million due to what the court called the developer's "brazen fraud and dishonesty". 

Mineral Resources has won a bid for more documents in its fight with the Pilbara Ports Authority over the validity of a channel charge. 

Built has lost its lawsuit against the Victorian Correctional Infrastructure Partnership over a dispute resolution mechanism in a construction subcontract for upgrades to the Metropolitan Remand Centre. 

Mineral Resources has won a bid for more documents in its fight with the Pilbara Ports Authority over the validity of a channel charge, which it argues was imposed to cover amounts owed to Chevron for construction costs. 

Deciding an issue that might take a class action against Ford to the High Court for a second time, a judge has found that used car owners can sue under the same consumer guarantee as someone who bought a new car. 

AstraZeneca has won an interlocutory injunction barring Pharmacor from making a generic version of its blockbuster diabetes drug Forxiga while a patent case over the drug proceeds.